Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.
A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along ...
A Missouri man was sentenced to 10 years in prison for orchestrating a Medicare fraud scheme that generated more than $174 million in genetic testing claims, according to a Dec. 12 news release from ...
This study came out of a multi-institutional collaboration called the BRCA BCY group, which is an international group of ...
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...
From mammography to genetic testing – everything every woman should know about early diagnosis and modern breast care ...
Laura Devlin noticed that her daughter, Penny, seemed unsteady on her feet. It took her seven years to find out why ...
A Mayo Clinic study reports that current genetic screening guidelines fall short in identifying the majority of individuals ...
While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have ...
Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only ...
Around 200 children across Europe were conceived from a single sperm donor unknowingly carrying a rare cancer-linked mutation. The tragedy exposes gaps in genetic screening and cross-border donor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback